Raffles Medical Group (RMG)

UOBKH ups Raffles Medical's TP as its transitional care facilities join Singapore's healthcare ecosystem - THE EDGE SINGAPORE

Broker's Calls

UOBKH ups Raffles Medical's TP as its transitional care facilities join Singapore's healthcare ecosystem

Raffles Medical Group boasts “healthy margins due to its asset-light nature”, say UOB Kay Hian Research analysts.
RHB maintains 'buy' on Raffles Medical Group following strong revenue and China's reopening - THE EDGE SINGAPORE

Broker's Calls

RHB maintains 'buy' on Raffles Medical Group following strong revenue and China's reopening

Covid-19 may be behind, but RHB still sees a lot of life in Raffles Medical Group.

Healthcare

Large-cap healthcare stocks: Hefty, hearty and healthy

Covid-19 may be over, but these hospital players are still seeing growth from the economic recovery.
Raffles Medical Group sees 2HFY2022 earnings increase by 87.5% y-o-y to $83.8 mil as foreign patients return - THE EDGE SINGAPORE

Results

Raffles Medical Group sees 2HFY2022 earnings increase by 87.5% y-o-y to $83.8 mil as foreign patients return

RMG has declared a final ordinary dividend of 3.8 cents per share, 35.7% higher y-o-y.

Broker's Calls

Analysts positive on Raffles Medical amid stronger-than-expected recovery for 3QFY2022

For 3QFY2022, the group reported revenue growth of 6.5% y-o-y to $199.5 million
Raffles Medical Group reports 23.6% surge in 3QFY2022 profit after tax of $38.3 mil - THE EDGE SINGAPORE

Results

Raffles Medical Group reports 62.1% surge in 3QFY2022 profit after tax of $38.3 mil

The group says that it expects to remain profitable for the rest of the year based on the current conditions.
Private hospitals may benefit from rise in Covid-19 cases: DBS - THE EDGE SINGAPORE

Broker's Calls

Private hospitals may benefit from rise in Covid-19 cases: DBS

DBS has kept “buy” on Raffles Medical Group and IHH Healthcare with target prices of $1.63 and RM7.90 ($2.37) respectively.

Broker's Calls

RHB lowers Raffles Medical's TP to $1.60 on declining revenue and cost headwinds

RHB analyst Shekhar Jaiswal also reduced his earnings estimates for the group by 3% each for the FY2023 and FY2024.

Broker's Calls

High inflation could benefit healthcare industry based on historical trends: DBS

DBS analyst Rachel Tan says the pricing power of healthcare service providers could offset the inflationary cost pressures.

Broker's Calls

Analysts mostly lift TPs on Raffles Medical Group on the back of record 1HFY2022 results

The analysts have also mostly raised their earnings or earnings per share estimates for the FY2022.
×